Amanote Research
Register
Sign In
An Overview of Severe Acute Respiratory SyndromeCoronavirus (SARS-CoV) 3CL Protease Inhibitors: Peptidomimetics and Small Molecule Chemotherapy
doi 10.1021/acs.jmedchem.5b01461.s001
Full Text
Open PDF
Abstract
Available in
full text
Date
Unknown
Authors
Unknown
Publisher
American Chemical Society (ACS)
Related search
Inhibition of SARS-CoV 3CL Protease by Flavonoids
Journal of Enzyme Inhibition and Medicinal Chemistry
Medicine
Drug Discovery
Pharmacology
Discovery of Baicalin and Baicalein as Novel, Natural Product Inhibitors of SARS-CoV-2 3CL Protease in Vitro
Prior Immunization With Severe Acute Respiratory Syndrome (SARS)-Associated Coronavirus (SARS-CoV) Nucleocapsid Protein Causes Severe Pneumonia in Mice Infected With SARS-CoV
Journal of Immunology
Allergy
Immunology
Characterization of SARS-CoV Main Protease and Identification of Biologically Active Small Molecule Inhibitors Using a Continuous Fluorescence-Based Assay
FEBS Letters
Genetics
Cell Biology
Molecular Biology
Biochemistry
Structural Biology
Biophysics
Severe Acute Respiratory Syndrome (SARS)
European Respiratory Journal
Medicine
Pulmonary
Respiratory Medicine
Severe Acute Respiratory Syndrome (SARS)
British Journal of Haematology
Hematology
Severe Acute Respiratory Syndrome (SARS)
Thorax
Pulmonary
Respiratory Medicine
Severe Acute Respiratory Syndrome (SARS)
Indian Journal of Pediatrics
Child Health
Pediatrics
Perinatology
Serological Assays for Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), March 2020
Eurosurveillance
Environmental
Virology
Public Health
Epidemiology
Medicine
Occupational Health
